Stock IPSEY IPSEN S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ipsen S.A. OTC Markets

Equities

IPSEY

US4626292050

Market Closed - OTC Markets
Other stock markets
 19:41:09 17/07/2024 BST 		5-day change 1st Jan Change
30.38 USD -0.26% Intraday chart for Ipsen S.A. +2.38% +3.05%
07-11 CAC40: maintains gains after reassuring US inflation figures CF
07-11 CAC40: rise without volume, W-Street at its zenith but falls back CF

Evolution of the average Target Price on Ipsen S.A.

Price target over the last 5 years

History of analyst recommendation changes

4aca83af4f229d41c8739f5fc732b49.HkvsIyJzJU5ddzQOY9_CFfe1cS2uwAcItiiEXtbgtgo.SwPcT2ZechEXIF13LJu0SrbGBxybhFBL9EHCE7KH_EZIOrt7TDQSPSVBeQ~93347022af387f8ac8622e3a135c9755

Analyst Recommendations on Ipsen S.A.

IPSEN : UBS remains positive ahead of quarterly results CF
Ipsen: share price soars, UBS confirms its recommendation CF
IPSEN : UBS remains Buy after FDA approval CF
Ipsen: share price up, analyst raises target CF
IPSEN : Barclays raises its target price CF
IPSEN : Better-than-expected Q1; guidance unchanged Alphavalue
IPSEN : Ipsen’s underlying fundamentals remain promising Alphavalue
Deutsche Bank Reduces Ipsen PT, Keeps Hold Rating MT
IPSEN : Deutsche Bank cuts its target CF
IPSEN : UBS reiterates its buy recommendation CF
IPSEN : In line Q4 sales; lower-than-expected 2024 guidance Alphavalue
IPSEN : Deutsche Bank lowers its target price CF
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD Alphavalue
IPSEN : UBS remains Buy after CMD CF
IPSEN : RBC maintains 'in-line performance' rating CF
IPSEN : Jefferies downgrades recommendation to 'hold CF
IPSEN : Modest Q3 sales growth; guidance unchanged Alphavalue
Ipsen: upbeat with broker upgrade CF
UBS Upgrades Ipsen to Buy from Neutral, Boosts PT MT
IPSEN : UBS raises its recommendation CF
IPSEN : RBC welcomes Cabometyx data CF
IPSEN : AlphaValue upgrades its recommendation to 'buy CF
IPSEN : Deutsche Bank raises its price target CF
Ipsen: share price rises, two analysts optimistic CF
IPSEN : A compelling small Pharma Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
111.2 EUR
Average target price
127.3 EUR
Spread / Average Target
+14.46%
High Price Target
165 EUR
Spread / Highest target
+48.38%
Low Price Target
110 EUR
Spread / Lowest Target
-1.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ipsen S.A.

alphavalue Anas Patel
Deutsche Bank Securities
UBS

Ratings for Ipsen S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IPN Stock
  4. IPSEY Stock
  5. Consensus Ipsen S.A.